Virtus Fund Advisers’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-916
Closed -$73K 567
2016
Q4
$73K Hold
916
﹤0.01% 447
2016
Q3
$73K Hold
916
﹤0.01% 457
2016
Q2
$72K Hold
916
﹤0.01% 445
2016
Q1
$51K Hold
916
﹤0.01% 467
2015
Q4
$57K Hold
916
﹤0.01% 444
2015
Q3
$58K Buy
+916
New +$65.4K ﹤0.01% 427
2015
Q1
Sell
-328
Closed -$21K 1100
2014
Q4
$21K Hold
328
﹤0.01% 932
2014
Q3
$20K Sell
328
-2,518
-88% -$164K ﹤0.01% 951
2014
Q2
$197K Buy
+2,846
New +$184K ﹤0.01% 976

Other funds holding STJ

Virtus Fund Advisers's STJ Position: Q1 2017 in Review

Virtus Fund Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 916 shares — an estimated $73K sold.

Virtus Fund Advisers first reported a position in STJ in Q2 2014 and held it in 9 quarters. The position peaked at $197K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Virtus Fund Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Virtus Fund Advisers sold 916 St Jude Medical shares in Q1 2017, an estimated $73K.
  • Virtus Fund Advisers first reported a position in St Jude Medical in Q2 2014 and held it in 9 quarters.
  • Virtus Fund Advisers's St Jude Medical position peaked at $197K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Virtus Fund Advisers's 13F filing for Q1 2017, filed 9 May 2017.